Elranatamab,Dexamethasone
Pfizer
['mmsm']
aa7: rr in all bdt exposures was 46%, vgpr and better 43%, in those exposed to car-t rr was 53%, while vgpr and better was 47% #mmsm #myeloma #usmirc #asco23 #medtwitter 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter